Imint has signed several promising deals during the last months, where we especially value the recent agreements covering use of additional Vidhance features. Sales are, however, still on a low level and we have consequently revised our estimates, resulting in an updated fair value range.
Read more and download the Research Update: https://goo.gl/pU8zuT
Start following companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye – Research Powered Investment Banking. https://www.redeye.se/about/
